## **Core Concept**
The question tests knowledge on the management of infections caused by methicillin-resistant *Staphylococcus aureus* (MRSA), focusing on the choice of antibiotic. MRSA infections are a significant concern due to their resistance to beta-lactam antibiotics, including methicillin. The treatment of MRSA infections requires antibiotics that are effective against these resistant strains.

## **Why the Correct Answer is Right**
Vancomycin is considered a drug of choice for the treatment of serious MRSA infections. It is a glycopeptide antibiotic that inhibits cell wall synthesis in bacteria and has been a mainstay in the treatment of MRSA infections for many years. Vancomycin's effectiveness against MRSA is well-documented, making it a preferred option for treating severe infections such as bacteremia, endocarditis, and pneumonia caused by MRSA.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that the emergence of vancomycin-resistant *Enterococci* (VRE) and reports of vancomycin-resistant *Staphylococcus aureus* (VRSA) have made it essential to use vancomycin judiciously. Monitoring for resistance and considering alternative treatments like daptomycin, linezolid, or clindamycin (depending on susceptibility) is crucial in the management of MRSA infections.

## **Correct Answer:** . Vancomycin